MAPT and Alzheimer disease: In early stages of Alzheimer’s disease, tau becomes hyperphosphorylated and mislocalized, which can contribute to its aggregation and toxicity (22, 23), and this hyperphosphorylation is mimicked in the C. elegans hTau-expressing model (9).